Recombinant Human PDE6G Protein，GST

Phosphodiesterase 6 gamma subunit (PDE6G) is a crucial component of the phototransduction cascade in retinal photoreceptor cells, where it plays a vital role in activating phosphodiesterase 6 (PDE6) to regulate cyclic GMP levels and facilitate visual signal processing. Mutations in the PDE6G gene have been implicated in various forms of retinal diseases, including retinitis pigmentosa and congenital stationary night blindness, leading to vision impairment or loss. Research on recombinant PDE6G proteins has gained momentum due to their potential applications in understanding the molecular mechanisms underlying these retinal disorders and developing therapeutic strategies. By producing and characterizing recombinant PDE6G, scientists can explore its biochemical properties, interaction with other proteins in the phototransduction cascade, and the effects of specific mutations. This knowledge is essential for unraveling the complex biology of vision and may pave the way for gene therapy approaches, protein replacement strategies, or pharmacological interventions aimed at restoring visual function in affected individuals. Thus, the study of PDE6G recombinant proteins not only enhances our fundamental understanding of retinal biochemistry but also opens up new avenues for innovative treatments for retinal degenerative diseases.